Brief: Inoviq Says Settled Legal Proceeding Related To Bard1 Performance Shares
28/11/2022 24:53
Nov 28 (Reuters) - INOVIQ Ltd IIQ.AX :
* SETTLED LEGAL PROCEEDING RELATED TO BARD1 PERFORMANCE
SHARES
* PLAINTIFFS TO RECEIVE BARD1 LUNG CANCER TEST IP AND A$1
MILLION
PAYMENT
* RETAINS BREAST AND OVARIAN CANCER IP AND RECEIVES 10% OF
FUTURE
SALES OF BARD1 LUNG CANCER TEST UNTIL EXPIRY OF PATENTS
Source text for Eikon: ID:nASXbSGJcV
Further company coverage: IIQ.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Inoviq
See all newsBrief: Inoviq Posts FY26 Net Loss After Tax A$7.5 Million
Brief: INOVIQ Requests Trading Halt
Brief: INOVIQ Says Peter Gunzburg Elected To Role Of Chairman
Brief: Inoviq Says Chairman David Williams To Step Down At Year-End
Australia's INOVIQ slips to 2-1/2-month low on $6.2 million discounted placement